Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -3.025% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCCCN(CC)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
b. CN(C)/C=C/C(=C\C(=O)C(F)(F)F)Nc1ccc(C(F)(F)F)cc1
c. Cc1ccc(OCC(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)c([N+](=O)[O-])n1
d. CCOc1ccc(OCC)c(NC(=O)C2CCCN(c3nc(C)cc(C)n3)C2)c1
e. COCCNC(=O)CN(c1ccccc1OC)S(C)(=O)=O
Answer: a. CCCCN(CC)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
CCCCN(CC)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
N-[2-[butyl(ethyl)amino]ethyl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide